title: Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl.
abstract: Oligo-acyl-lysyls (OAKs) are synthetic mimics of host defense peptides known to exert antibacterial activity both in cultures and in animal models of disease. Here, we investigated how environmental conditions (temperature, pH, and ionic strength) affect the antibacterial properties of an octamer derivative, C(12)K-7alpha(8). Data obtained with representative bacteria, including the Gram-negative bacterium Escherichia coli and the Gram-positive bacteria Listeria monocytogenes and Staphylococcus aureus, showed that OAK's potency was proportionally affected by pH changes and subsided essentially throughout a wide range of salt concentrations and temperature values, whereas antistaphyloccocal activity was relatively more vulnerable. It was rather the mode of action that was most susceptible to the environmental changes. Thus, OAK's bactericidal effect was limited to a growth-inhibitory effect under acidic pH, low temperatures, or high salt concentrations, whereas basic pH or high temperatures have enhanced the bactericidal kinetics. Properties of binding to model phospholipid membranes provided evidence that correlated the differential modes of action with variable binding affinities. Interestingly, combination of the optimal incubation conditions resulted in a remarkable increase in potency, as expressed by a 16- to 32-fold reduction in the MIC value and by much faster bactericidal rates (>99% death induced within minutes versus hours) compared with the standard incubation conditions. Collectively, the data suggest that OAKs might be useful in developing design strategies for robust antimicrobial peptides that are able to affect a pathogen's viability under a large spectrum of incubation conditions.
authors.affiliation: Laboratory of Host Defense Peptides Investigation (HDPI), Department of Biotechnology & Food Engineering, Technion-Israel Institute of Technology, Haifa, Israel.
authors.forename: Yair
authors.initials: Y
authors.lastname: Goldfeder
authors.forename: Fadia
authors.initials: F
authors.lastname: Zaknoon
authors.forename: Amram
authors.initials: A
authors.lastname: Mor
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry / Q000494:pharmacology; D015195:Drug Design; D004926:Escherichia coli / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D008089:Listeria monocytogenes / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D018716:Molecular Mimicry; D009842:Oligopeptides / Q000737:chemistry* / Q000494:pharmacology*; D009994:Osmolar Concentration; D013211:Staphylococcus aureus / Q000187:drug effects; D013329:Structure-Activity Relationship; D013696:Temperature
chemical_list: D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D009842:Oligopeptides
references.citation: Peptides. 2002 Dec;23(12):2071-83
references.pmid: 12535685
references.citation: Antimicrob Agents Chemother. 2009 Oct;53(10):4231-9
references.pmid: 19620333
references.citation: Peptides. 2003 Nov;24(11):1815-21
references.pmid: 15019214
references.citation: Biopolymers. 2002;66(4):236-48
references.pmid: 12491537
references.citation: Antimicrob Agents Chemother. 2008 Dec;52(12):4308-14
references.pmid: 18838600
references.citation: Chem Biol. 2006 Apr;13(4):427-35
references.pmid: 16632255
references.citation: FASEB J. 2009 Dec;23(12):4299-307
references.pmid: 19706728
references.citation: Int J Pept Protein Res. 1990 Mar;35(3):161-214
references.pmid: 2191922
references.citation: Nat Rev Microbiol. 2005 Mar;3(3):238-50
references.pmid: 15703760
references.citation: J Am Chem Soc. 2008 Dec 10;130(49):16622-32
references.pmid: 19049458
references.citation: Pharmacol Rev. 2003 Mar;55(1):27-55
references.pmid: 12615953
references.citation: Nature. 2002 Jan 24;415(6870):389-95
references.pmid: 11807545
references.citation: Int J Food Microbiol. 2007 Jan 1;113(1):1-15
references.pmid: 17010463
references.citation: Microbiol Mol Biol Rev. 2007 Jun;71(2):377-97
references.pmid: 17554049
references.citation: J Am Chem Soc. 2009 Jul 22;131(28):9735-45
references.pmid: 19601684
references.citation: Chem Biol. 2009 Dec 24;16(12):1250-8
references.pmid: 20064435
references.citation: Infect Immun. 1993 Jul;61(7):2978-84
references.pmid: 8514403
references.citation: Biochemistry. 2003 Nov 11;42(44):12866-74
references.pmid: 14596600
references.citation: Clin Infect Dis. 2008 Dec 15;47(12):1537-45
references.pmid: 18990064
references.citation: Int J Food Microbiol. 2002 Feb 5;72(3):225-31
references.pmid: 11845821
references.citation: J Bacteriol. 2004 Sep;186(18):6032-41
references.pmid: 15342572
references.citation: Biochim Biophys Acta. 2009 Aug;1788(8):1582-92
references.pmid: 19028449
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2794-9
references.pmid: 18287037
references.citation: Int J Food Microbiol. 2007 Nov 30;120(1-2):51-70
references.pmid: 17614151
references.citation: Acc Chem Res. 2008 Oct;41(10):1366-75
references.pmid: 18578513
references.citation: Proc Biol Sci. 2006 Jan 22;273(1583):251-6
references.pmid: 16555795
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):6968-73
references.pmid: 19359494
references.citation: Lancet Infect Dis. 2003 Jul;3(7):405-12
references.pmid: 12837345
references.citation: Infect Immun. 1997 Jul;65(7):2898-903
references.pmid: 9199465
references.citation: Mol Microbiol. 1998 Dec;30(5):905-10
references.pmid: 9988468
references.citation: Int J Syst Bacteriol. 1999 Apr;49 Pt 2:653-62
references.pmid: 10408878
references.citation: Nat Rev Microbiol. 2006 Jun;4(6):423-34
references.pmid: 16710323
references.citation: Antimicrob Agents Chemother. 2006 Feb;50(2):490-7
references.pmid: 16436701
references.citation: J Leukoc Biol. 2005 Apr;77(4):466-75
references.pmid: 15582982
references.citation: Chem Biol. 2008 Apr;15(4):354-62
references.pmid: 18420142
references.citation: Nat Biotechnol. 2007 Jun;25(6):657-9
references.pmid: 17529972
references.citation: J Am Chem Soc. 2008 Oct 29;130(43):14346-52
references.pmid: 18826221
references.citation: Appl Environ Microbiol. 1997 Sep;63(9):3451-7
references.pmid: 9292996
references.citation: Biochim Biophys Acta. 2009 Aug;1788(8):1570-81
references.pmid: 19046939
references.citation: Antimicrob Agents Chemother. 2007 May;51(5):1753-9
references.pmid: 17307975
references.citation: Biochim Biophys Acta. 1999 Dec 15;1462(1-2):11-28
references.pmid: 10590300
references.citation: BioDrugs. 2003;17(4):233-40
references.pmid: 12899640
references.citation: J Am Chem Soc. 2007 Dec 19;129(50):15474-6
references.pmid: 18034491
references.citation: FASEB J. 2010 Jun;24(6):1904-13
references.pmid: 20124435
references.citation: Nat Biotechnol. 2006 Dec;24(12):1551-7
references.pmid: 17160061
references.citation: Curr Microbiol. 2008 Dec;57(6):552-7
references.pmid: 18810542
references.citation: FEBS J. 2009 Nov;276(22):6474-82
references.pmid: 19817857
references.citation: Appl Environ Microbiol. 1999 Feb;65(2):618-25
references.pmid: 9925591
references.citation: J Food Prot. 1995 Apr;58(4):381-388
references.pmid: 31137349
references.citation: Curr Eye Res. 2005 Jul;30(7):505-15
references.pmid: 16020284
references.citation: FASEB J. 2008 Aug;22(8):2652-61
references.pmid: 18385215
references.citation: Curr Opin Biotechnol. 2008 Dec;19(6):620-7
references.pmid: 18996193